Aleksandra G. W.
- Country
- Poland
- Department
- N/A
Research Overview
- Phase 3 Randomized Study of Gedatolisib Combination Therapy versus Standard Endocrine Therapy in HR‑Positive, HER2‑Negative Advanced Breast Cancer Post‑CDK4/6 Inhibitor
- Phase 3 Randomized Study of Sacituzumab Tirumotecan and Pembrolizumab Versus Physician's Choice in Triple-Negative Breast Cancer Post-Neoadjuvant Therapy
- Phase 2 Randomized Study of PF-07220060 and Letrozole Versus Letrozole in Postmenopausal Women with HR-Positive, HER2-Negative Breast Cancer
Data & Insights
Has run more than one trial at 219 of 513 partner sites.
Specializations
Breast Cancer Treatment Innovation
The investigator specializes in treating various forms of hormone receptor-positive breast cancer, with particular emphasis on early-stage and advanced/metastatic disease. Their research encompasses innovative therapeutic approaches for breast cancer management.
- Hormone Receptor-Positive (HR+) Breast Cancer
- HER2-Negative Breast Cancer
- Metastatic Breast Cancer Treatment
Their work extends to evaluating novel therapeutic compounds and comparing their efficacy with standard endocrine therapies.
Endocrine Therapy Research
The investigator focuses on advancing endocrine therapy approaches for breast cancer treatment, including research into new therapeutic agents and their combinations with existing treatments.
- Adjuvant Endocrine Therapy
- Novel Endocrine Agents
- Treatment Resistance Management
Their research includes evaluation of targeted therapies in combination with endocrine treatments for improved patient outcomes.
Symptom Management
The investigator studies treatments for managing vasomotor symptoms in cancer patients, particularly focusing on side effects associated with breast cancer therapy.
- Cancer Treatment Side Effects
- Quality of Life Improvement
- Supportive Care Strategies
Their work includes investigating therapeutic solutions for treatment-related symptoms in breast cancer patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
